From professional translators, enterprises, web pages and freely available translation repositories.
der vil også deltage repræsentanter for edqm i en række af emea’ s arbejdsgrupper.
financial control the focus will be on implementation of the integrated management systems with continual improvement of emea processes and the development of an operational risk register as objectives, underpinned by internal audits and competence development.
programmet for stikprøvekontrol og afprøvning af centralt godkendte lægemidler videreføres i 2002 i samarbejde med edqm.
the programme for sampling and testing of centrally authorised products will continue in 2002, in collaboration with the edqm.
der foretages stikprøveindsamling og afprøvning af centralt godkendte lægemidler i samarbejde med det europæiske direktorat for lægemiddelkvalitet (edqm) .
sampling and testing of centrally authorised medicines is performed in collaboration with the european directorate for the quality of medicines (edqm) .
stikprøveundersøgelser og afprøvning af lægemidlerne koordineres af edqm og udføres af netværket af officielle lægemiddelkontrollaboratorier i eu og eØs/ efta - medlemsstaterne.
sampling and testing of the products is coordinated by edqm and is carried out by the network of official medicines testing laboratories of the eu and eea-efta member states.
der vil også deltage repræsentanter for edqm i en række af emea's arbejdsgrupper.1. 9 integreret kvalitetsstyring og finanskontrolder vil blive sat fokus på at gennemføre integrerede forvaltningssystemer med det formål til stadighed at forbedre emea's processer og udvikle et operationelt risikoregister understøttet af interne revisioner og kompetenceudvikling.
the agency will continue its commitment to the international conferences on harmonisation processes for human and veterinary medicines (ich and vich) and will in particular contribute to the sixth ich conference to be held in osaka, japan in 2003.cooperation with health authorities such as the us food and drug administration (fda) will be strengthened.the visiting experts programmes will continue in 2003 with the emea welcoming experts from the canadian and japanese authorities in 2003.there will be closer cooperation with the world health organization, especially in the field of pharmacovigilance.